Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Confusion About Health Impacts of Nicotine Hampers Efforts to Stop Smoking and Save Lives


News provided by

The Foundation for a Smoke-Free World

20 Jul, 2020, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, July 20, 2020 /PRNewswire/ -- New research published in Drugs and Alcohol Today found that the public struggles to distinguish between the health impacts of nicotine and those of tobacco, complicating efforts to help smokers switch to science-based smoking cessation and harm reduction strategies. "Perceptions of Nicotine in Current and Former Users of Tobacco and Tobacco Harm Reduction Products from Seven Countries," analyzes the perceptions of more than 55,000 nicotine consumers across seven geographically dispersed countries against media coverage of nicotine research and products.

The "Perceptions of Nicotine" publication concludes that significant public awareness gaps exist between science and public perception concerning the role that nicotine can play in affecting users' behavior and health as a core component of harm reduction products (patches, gums, e-cigarettes, etc.). This is despite the agreement among most medical researchers that nicotine is not a carcinogen, and that the harm from cigarettes comes predominantly from other ingredients found in tobacco, including tar.

"The fact that the majority of smokers don't know the difference between nicotine and cigarettes is troubling for anyone committed to ending the tobacco epidemic," said Dr. Sarah Rajkumar, Director of Epidemiology for Health, Science, and Technology at the Foundation for a Smoke-Free World, an author of the report. "We would like to work with the media and communications experts to help them provide clearer communications about the current state of knowledge surrounding the health impacts of nicotine versus tobacco. The goal is to educate policymakers on the importance of addressing harm reduction products differently than combustible tobacco."

Confusion Over Health Risks
A 2017 survey found that in many countries a vast majority of smokers use the terms "nicotine" and "cigarettes" interchangeably, suggesting a lack of awareness that nicotine consumption via tobacco harm reduction (THR) products does not carry the same health risks as cigarettes.

The study also examines the Global State of Smoking Poll 2019 which surveyed over 50,000 current and former tobacco users in the U.S., U.K., India, Greece, Norway, Japan and South Africa. The survey revealed 65.7% of adult participants believe nicotine causes cancer. This misperception persists even among people who had successfully quit smoking. A majority of quitters in all countries thought nicotine was harmful, while the proportion of quitters who believed nicotine is the primary cause of cancer was slightly higher than among current users.

Popular Media Coverage Seen as Contributing to Misperception 
To better understand the source of the misperception, the "Perceptions of Nicotine" report also examined media dialogue and public reporting on nicotine in top-tier, English language outlets across the U.S., U.K., India, and South Africa between January 2019 and March 2020.

The results indicated a consistent pattern of negative media coverage mentioning nicotine, with nearly one third of stories referencing nicotine's addictive nature and the dangers of dependency. While much of the commentary included limited discussion about the efficacy of e-cigarettes as a smoking cessation tool, there was no media coverage on the potential therapeutic uses of nicotine. Commentary failed to mention, for example, use of nicotine for possible protection against Parkinson's or Alzheimer's disease--applications that are being actively explored. 

Call for Accuracy and Transparency in Public Dialogue
Dr. Rajkumar's article concludes with a call-to-action to enhance accurate characterizations of the science behind nicotine research and tobacco harm reduction (THR) products to ensure the global smoker population has access to the resources they need to quit.

"The data is clear that public perceptions of nicotine often conflict with available scientific evidence," said Dr. Derek Yach, president of the Foundation for a Smoke-Free World. "High levels of confusion – driven by deliberate mischaracterizations of nicotine – hamper the adoption of science-based cessation and harm reduction strategies to reduce death and disease from smoking."

The "Perceptions of Nicotine" article was published as part of a broader special edition of Drugs and Alcohol Today, featuring forthcoming research developed by FSFW staff and global health experts. The additional articles cover an array of issues related to tobacco control, science-based cessation, and harm reduction strategies.

The Foundation for a Smoke-Free World is an independent, US nonprofit 501(c)(3) organization with the purpose of improving global health by ending smoking in this generation. The Foundation supports its mission through three core pillars: Health, Science and Technology; the Agricultural Transformation Initiative; and Industry Transformation. The Foundation has received contributions from Philip Morris International (PMI) in 2018 and 2019 each in the amount of US$80 million. PMI has pledged to contribute $80 million annually for the next ten years. Under the Foundation's bylaws and pledge agreement, PMI and the tobacco industry, generally, are precluded from having any control or influence over how the Foundation spends its funds or focuses its activities. The Foundation's acceptance of the contributions does not constitute an endorsement by the Foundation of any of the pledger's products. For more information about the Foundation, please visit www.smokefreeworld.org.

For Media:
Nicole Bradley
Vice President of Communications
Nicole.Bradley@smokefreeworld.org

Related Links

http://www.smokefreeworld.org

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.